MID-VOLUME · HOSP-HEAVY
candesartan Side Effects
candesartan (also sold as Atacand) sits MID-VOLUME #178 of 524 by FAERS report count. Lead signal: HOSP-HEAVY - 52.7% mention hospitalization (17,659 reports). Demographics and serious-outcome tables follow.
Data updated 2026-05-15
- 33,477
- FAERS reports
FDA Adverse Event Reporting System extract for candesartan. Stamp set CASELOAD · DEATH-HEAVY · HOSP-HEAVY. How figures are compiled.
candesartan: 52.7% mention hospitalization (17,659 reports). Death stamp DEATH-HEAVY; volume band MID-VOLUME #178 of 524 by FAERS report count.
Mid-book FAERS page for candesartan (Atacand) (33,477 reports). Signature HOSP-HEAVY. Dominant age band on file: 75+. Educational reference only.
Counts from the openFDA FAERS extract (2004–2025). Stamps CASELOAD · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
DYSPNOEA leads 3,169 of 33,477 reports
Who reports · age peak 75+ (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 75+ (9,109 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (4,308 reports, 12.9%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| GENERAL PHYSICAL HEALTH DETERIORATION | 945 |
| CONDITION AGGRAVATED | 841 |
| ASTHENIA | 799 |
| MATERNAL EXPOSURE DURING PREGNANCY | 796 |
| PEMPHIGUS | 790 |
| FOLLICULITIS | 777 |
| SYSTEMIC LUPUS ERYTHEMATOSUS | 768 |
| TYPE 2 DIABETES MELLITUS | 766 |
| BURSITIS | 763 |
| PAIN | 763 |
| PERICARDITIS | 760 |
| GLOSSODYNIA | 758 |
| SYNOVITIS | 753 |
| HYPOAESTHESIA | 749 |
| HYPERTENSION | 747 |
| PNEUMONIA | 747 |
| DIARRHOEA | 745 |
| CONFUSIONAL STATE | 743 |
Reactions in Hospitalization Reports
Hospitalization is HEAVY (17,659, 52.7% of the book). Top reactions in those rows:
| Reaction | Reports |
|---|---|
| DYSPNOEA | 2,128 |
| GENERAL PHYSICAL HEALTH DETERIORATION | 1,987 |
| NAUSEA | 1,835 |
| FATIGUE | 1,815 |
| DIARRHOEA | 1,677 |
| VOMITING | 1,620 |
| DIZZINESS | 1,586 |
| PAIN | 1,548 |
| ASTHENIA | 1,474 |
| PNEUMONIA | 1,423 |
| HEADACHE | 1,411 |
| FALL | 1,403 |
| CONDITION AGGRAVATED | 1,296 |
| HYPERTENSION | 1,260 |
| ACUTE KIDNEY INJURY | 1,240 |
| PYREXIA | 1,231 |
| MALAISE | 1,227 |
| ARTHRALGIA | 1,181 |
How to read candesartan FAERS figures (CASELOAD · DEATH-HEAVY · HOSP-HEAVY)
FAERS holds 33,477 voluntary reports linked to candesartan (Atacand), 2004-2025. Death is listed on 4,308 (12.9%). Hospitalization appears on 17,659 (52.7%). Top co-reported indication: Product Used For Unknown Indication.
Mid-volume extract - treat DEATH-HEAVY · HOSP-HEAVY as signal-detection rates next to 52.7% mention hospitalization (17,659 reports).
Read with candesartan
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-HEAVY stamps.
ABS(total_reports) peer at 33,611 FAERS cases (Δ 134 heavier vs candesartan); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's CASELOAD · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 33,620 FAERS cases (Δ 143 heavier vs candesartan); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's CASELOAD · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 33,247 FAERS cases (Δ 230 lighter vs candesartan); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's CASELOAD · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 33,054 FAERS cases (Δ 423 lighter vs candesartan); DEATH-HEAVY · HOSP-MID · SEX-BALANCED vs this page's CASELOAD · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
candesartan stamps DEATH-HEAVY · HOSP-HEAVY; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload CASELOAD and the label guide.